Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT06630260 |
| Title | 5G-RUBY: Avutometinib and Defactinib in Malignant Brain Tumours (5G-RUBY) |
| Acronym | 5G-RUBY |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | Institute of Cancer Research, United Kingdom |
| Indications | |
| Therapies | |
| Age Groups: | adult | child | senior |
| Covered Countries | GBR |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Cambridge University Hospitals | RECRUITING | Cambridge | CB2 0QQ | United Kingdom | Details | |
| The Royal Marsden Hospital - Drug Development Unit | RECRUITING | Sutton | SM2 5PT | United Kingdom | Details | |
| The Royal Marsden Hospital - Neuro-Oncology Unit | NOT_YET_RECRUITING | Sutton | SM2 5PT | United Kingdom | Details |